These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23819713)

  • 1. Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan.
    Iba T
    J Thromb Haemost; 2013 Nov; 11(11):2076-8. PubMed ID: 23819713
    [No Abstract]   [Full Text] [Related]  

  • 2. Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal.
    Wada H; Thachil J; Di Nisio M; Kurosawa S; Gando S; Toh CH;
    J Thromb Haemost; 2013 Nov; 11(11):2078-9. PubMed ID: 23927431
    [No Abstract]   [Full Text] [Related]  

  • 3. Expert consensus for the treatment of disseminated intravascular coagulation in Japan.
    Wada H; Asakura H; Okamoto K; Iba T; Uchiyama T; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S; Kushimoto S; Seki Y; Madoiwa S; Maruyama I; Yoshioka A;
    Thromb Res; 2010 Jan; 125(1):6-11. PubMed ID: 19782389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.
    Iba T; Gando S; Thachil J
    J Thromb Haemost; 2014 Jul; 12(7):1010-9. PubMed ID: 24801203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disseminated intravascular coagulation: role of the International Society on Thrombosis and Haemostasis (ISTH) diagnostic scoring system].
    Bouzidi S; Daiki M; Nasr AA; Nsiri K; Layouni S; Hajjej Z; Fekih-Mrissa N; Ferjani M; Nsiri B
    Pan Afr Med J; 2020; 36():154. PubMed ID: 32874418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Emergency therapy of disseminated intravascular coagulation].
    Yawata Y
    Nihon Naika Gakkai Zasshi; 1995 Nov; 84(11):1858-64. PubMed ID: 8568387
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.
    Wada H; Gabazza EC; Asakura H; Koike K; Okamoto K; Maruyama I; Shiku H; Nobori T
    Am J Hematol; 2003 Sep; 74(1):17-22. PubMed ID: 12949885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic criteria for overt-disseminated intravascular coagulation (DIC) established by International Society of Thrombosis and Haemostasis (ISTH)].
    Mori Y; Wada H
    Rinsho Byori; 2011 Feb; Suppl 147():36-41. PubMed ID: 21761747
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer-associated thrombosis and bleeding.
    Ikezoe T
    Int J Hematol; 2024 May; 119(5):493-494. PubMed ID: 38311665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
    García Fernández JR; López Berenguel F; Ais C
    An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of disseminated intravascular coagulation].
    Asakura H
    Rinsho Ketsueki; 2012 Oct; 53(10):1720-9. PubMed ID: 23037744
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment with low-molecular-weight heparin of disseminated intravascular coagulation secondary to an aortic aneurysm].
    Callejas Rubio JL; Ortego Centeno N; Díez Ruiz A; Bermúdez García JM
    Rev Clin Esp; 1998 Nov; 198(11):781-2. PubMed ID: 9883061
    [No Abstract]   [Full Text] [Related]  

  • 13. Current drug treatment strategies for disseminated intravascular coagulation.
    de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
    Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trials of anticoagulants and anticoagulant factor concentrates for the management of DIC in Japan].
    Okamoto K; Tamura T; Yamaguchi K
    Rinsho Byori; 2011 Feb; Suppl 147():95-103. PubMed ID: 21761755
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparins in sepsis-induced disseminated intravascular coagulation: low weight-high impact?
    Lehmann C; Usichenko TI; Pavlovic D
    Crit Care Med; 2005 Jun; 33(6):1455-7. PubMed ID: 15942389
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progresses in characteristics and diagnostic methods of neonatal diffuse intravascular coagulation].
    Xu J; Pan XN
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):227-30. PubMed ID: 23751587
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the best heparin to treat sepsis with?
    van Roessel S; van der Laan AM; de Pont AC
    Crit Care Med; 2015 Jun; 43(6):e212-3. PubMed ID: 25978176
    [No Abstract]   [Full Text] [Related]  

  • 18. Should heparin be used to treat patients with severe sepsis?
    Kalil AC
    Crit Care Med; 2015 Mar; 43(3):694-5. PubMed ID: 25700050
    [No Abstract]   [Full Text] [Related]  

  • 19. The authors reply.
    Zarychanski R; Kumar A
    Crit Care Med; 2015 Jun; 43(6):e213. PubMed ID: 25978177
    [No Abstract]   [Full Text] [Related]  

  • 20. Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.
    Wang D; Yang Y; Wang Y; Proulle V; Andreasen PA; Hong W; Chen Z; Huang M; Xu P
    Biomed Pharmacother; 2020 Oct; 130():110528. PubMed ID: 32702634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.